Managed Healthcare Executive12m
62% of Americans Believe the Government Should Provide Healthcare Coverage
Now at the highest percentage in over a decade, this number has rebounded from 42% in 2013 during the rollout of the ...
Managed Healthcare Executive50m
Savara Begins Rolling BLA for Molbreevi for Rare Lung Disease
If approved, Molbreevi could be the first FDA-approved treatment for patients with autoimmune pulmonary alveolar proteinosis, ...
Managed Healthcare Executive5h
FDA Approves Tryngolza for Rare Cholesterol Disease
Tryngolza is once-monthly, subcutaneous RNA-targeted therapy and is expected to be available by the end of the year with a ...
Managed Healthcare Executive17h
Stripped Down Spending Bill, Backed By Trump, Does Not Pass
The new, now-defeated bill eliminated the PBM reform measures included in a larger spending bill that the president-elect and ...
Managed Healthcare Executive20h
Sex Lives Better After Atopic Derm Drugs, Patients Say
A new study shows that nearly 90% of patients with moderate-to-severe atopic dermatitis (AD) reported their condition ...
Managed Healthcare Executive20h
Mortality Rates and Comorbidities Associated With Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
Anna Podolanczuk, M.D., M.S., discusses how the mortality rates for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are impacted by comorbidities, including ...